It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Background: Limited data on electronic cigarette prevalence, patterns, and settings of use are available from several European countries.
Methods: Within the TackSHS project, a face-to-face survey was conducted in 2017–2018 in 12 European countries (Bulgaria, England, France, Germany, Greece, Ireland, Italy, Latvia, Poland, Portugal, Romania and Spain). Overall, 11,876 participants, representative of the population aged ⩾15 years in each country, provided information on electronic cigarette.
Results: 2.4% (95% confidence interval [CI], 2.2–2.7%) of the subjects (2.5% among men and 2.4% among women; 0.4% among never, 4.4% among current- and 6.5% among ex-smokers) reported current use of electronic cigarette, ranging from 0.6% in Spain to 7.2% in England. Of the 272 electronic cigarette users, 52.6% were dual users (ie, users of both electronic and conventional cigarettes) and 58.8% used liquids with nicotine. In all, 65.1% reported using electronic cigarette in at least one indoor setting where smoking is forbidden; in particular, at workplaces (34.9%) and bars and restaurants (41.5%). Multivariable logistic regression analysis showed that electronic cigarette use was lower among older individuals (P for trend <0.001) and higher among individuals with high level of education (P for trend = 0.040). Participants from countries with higher tobacco cigarette prices more frequently reported electronic cigarette use (odds ratio 3.62; 95% CI, 1.80–7.30).
Conclusion: Considering the whole adult population of these 12 European countries, more than 8.3 million people use electronic cigarettes. The majority of users also smoked conventional cigarettes, used electronic cigarettes with nicotine, and consumed electronic cigarettes in smoke-free indoor areas.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Lugo, Alessandra
; Chiara Stival
Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Sonia Cerrai
Epidemiology and Health Research Lab, Institute of Clinical Physiology, National Research Council of Italy (IFC-CNR); Luke Clancy
TobaccoFree Research Institute Ireland; Filippos T Filippidis
Department of Primary Care and Public Health, Imperial College London; Giuseppe Gorini
Oncologic Network, Prevention and Research Institute (ISPRO); Maria José Lopez
Agència de Salut Pública de Barcelona
Departament de Ciències Experimentals i de la Salut (DCEXS), Universitat Pompeu Fabra
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP)
Sant Pau Institute of Biomedical Research (IIB Sant Pau); Ángel López-Nicolás
Polytechnic University of Cartagena (UPCT); Sabrina Molinaro
Epidemiology and Health Research Lab, Institute of Clinical Physiology, National Research Council of Italy (IFC-CNR); Anna Odone
School of Medicine, University Vita-Salute San Raffaele
Department of Public Health, Experimental and Forensic Medicine, University of Pavia; Joan B Soriano
Hospital Universitario La Princesa (IISP)
Consortium for Biomedical Research in Respiratory Diseases (CIBERES); Tigova, Olena
; Piet A van den Brandt
Maastricht University Medical Centre, GROW- School for Oncology and Developmental Biology, Department of Epidemiology
Maastricht University Medical Centre, CAPHRI- School for Public Health and Primary Care, Department of Epidemiology; Constantine I Vardavas
Hellenic Cancer Society
School of Medicine, University of Crete; Esteve Fernandez
Consortium for Biomedical Research in Respiratory Diseases (CIBERES)
Tobacco Control Research Group, Epidemiology and Public Health Research Programme, Institut d’Investigació Biomèdica de Bellvitge-IDIBELL
Tobacco Control Unit, WHO collaborating center on tobacco control, Institut Català d’Oncologia-ICO
School of Medicine and Health Sciences, Campus of Bellvitge, Universitat de Barcelona




